Patent holdings for IPC class A61K 31/485

Total number of patents in this class: 3246

10-year publication summary

442
368
337
340
312
257
218
231
200
58
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Antecip Bioventures II LLC
360
235
Purdue Pharma L.P.
494
136
Alkermes Pharma Ireland Limited
256
52
Purdue Pharmaceuticals L.P.
47
47
Nalpropion Pharmaceuticals LLC
71
44
Indivior UK Limited
192
42
Ldn Pharma Limited
44
39
Toray Industries, Inc.
7045
34
Euro-celtique S.A.
88
33
Zevra Therapeutics, Inc.
109
32
SpecGx LLC
186
31
LTS Lohmann Therapie-Systeme AG
685
30
Trevi Therapeutics, Inc.
38
27
Rhodes Technologies
56
25
Nektar Therapeutics
422
22
Ohemo Life Sciences Inc
23
22
Camurus AB
147
20
Mallinckrodt LLC
131
20
Medrx Co., Ltd.
125
20
Nippon Chemiphar Co., Ltd.
225
20
Other owners 2315